JPMorgan Chase & Co. Grows Position in Amdocs Limited $DOX

JPMorgan Chase & Co. raised its position in Amdocs Limited (NASDAQ:DOX) by 41.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 376,039 shares of the technology company’s stock after acquiring an additional 109,915 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.33% of Amdocs worth $30,854,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Amundi raised its holdings in shares of Amdocs by 73.0% in the 1st quarter. Amundi now owns 13,778 shares of the technology company’s stock valued at $1,217,000 after purchasing an additional 5,816 shares in the last quarter. Millennium Management LLC increased its holdings in Amdocs by 458.3% in the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after buying an additional 55,038 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Amdocs by 12.6% in the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock valued at $30,300,000 after buying an additional 37,087 shares during the last quarter. Empowered Funds LLC raised its stake in Amdocs by 12.0% in the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock valued at $1,462,000 after buying an additional 1,709 shares in the last quarter. Finally, Jane Street Group LLC lifted its holdings in Amdocs by 195.4% during the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after buying an additional 76,683 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of DOX opened at $69.80 on Friday. The company’s 50 day simple moving average is $77.63 and its 200-day simple moving average is $80.53. The firm has a market cap of $7.53 billion, a PE ratio of 13.50, a price-to-earnings-growth ratio of 1.23 and a beta of 0.40. Amdocs Limited has a 12-month low of $65.74 and a 12-month high of $95.41. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the business earned $1.66 EPS. Amdocs’s quarterly revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be given a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 annualized dividend and a yield of 3.3%. Amdocs’s payout ratio is presently 40.81%.

Amdocs News Roundup

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs announced a multi‑year strategic collaboration with Amazon Web Services to combine Amdocs’ aOS agentic operating system with AWS AI and cloud capabilities to drive telecom modernization — a material commercial & product endorsement that supports future revenue growth. MWC 2026: Amdocs and AWS Announce Multi-Year Strategic Collaboration to Accelerate AI-Driven Telecom Modernization
• Positive Sentiment: Amdocs announced a collaboration with Microsoft to deliver AI‑accelerated application modernization (Amdocs Agentic Services + Microsoft AI), which can expand enterprise services and upsell opportunities. MWC 2026: Amdocs Collaborates with Microsoft to Bring AI-Accelerated Application Modernization to Enterprises
• Positive Sentiment: Amdocs partnered with Google Cloud to combine Gemini Enterprise CX with Amdocs’ Cognitive Core to create an agentic telco contact center — another strategic cloud/A.I. endorsement that could help win telco transformation deals. MWC 2026: Amdocs Collaborates with Google Cloud to Accelerate AI Adoption and Power the Agentic Telco Contact Center
• Positive Sentiment: Zacks Research raised multiple near‑ and medium‑term EPS forecasts (including FY2026/FY2027/FY2028 upgrades and several quarterly raises), which supports a more constructive earnings outlook and could underpin valuation. See Zacks coverage for context. Amdocs (DOX) is a Top-Ranked Growth Stock: Should You Buy?
• Neutral Sentiment: Published short‑interest notices show zero reported short interest and anomalous “NaN” increases across several February reporting dates — this appears to be a data/reporting issue and implies no visible short‑squeeze pressure at present.
• Negative Sentiment: Zacks trimmed its Q2 2026 EPS estimate from $1.60 to $1.50 in the same round of updates — a modest near‑term earnings downgrade that could temper sentiment around the next quarter.
• Negative Sentiment: Technically, the share price is below both the 50‑day and 200‑day moving averages noted in recent quotes, which can invite short‑term selling/ profit‑taking even amid positive fundamental headlines.

Wall Street Analyst Weigh In

DOX has been the subject of several analyst reports. Stifel Nicolaus lowered their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Barclays cut their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Finally, Bank of America reduced their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $92.33.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.